The right drug at the right dose to the right patient: the value of pharmacogenomic information

Veracuity Blog The right drug at the right dose to the right patient: the value of pharmacogenomic information In April 2019, Mozilla internet health report published an article “23 reasons not to reveal your DNA” [1]. The primary reasons why people should worry about sharing their DNA with strangers are quite obvious – privacy concerns,…

Details

Pharmacovigilance at a crossroads

Veracuity Blog Pharmacovigilance at a crossroads The global pharmacovigilance market is growing and is still expected to grow. In 2013, post-market safety surveillance accounted for 60% of the global pharmacovigilance market and should reach $6 billion by 2020. Main drivers for increased reporting of adverse drug reactions include compliance requirements and liability resulting from high-profile…

Details